Reduced adherence to antiretroviral therapy is associated with residual low-level viremia

References

• Antiretroviral Therapy Cohort CollaborationZwahlenMHarrisRMayMMortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countriesInt J Epidemiol20093861624163319820106
   PubMed Web of Science ®Google Scholar
• WoodEHoggRSYipBHarriganPRMontanerJSWhy are baseline HIV RNA levels 100,000 copies/mL or greater associated with mortality after the initiation of antiretroviral therapy?J Acquir Immune Defic Syndr200538328929515735446
   PubMed Web of Science ®Google Scholar
• MaggioloFAiroldiMKleinloogHDEffect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patientsHIV Clin Trials20078528229217956829
   PubMed Web of Science ®Google Scholar
• Guidelines for treatment of HIV-positive adults in EuropeGuidelines Chair and Coordinator: Lundgren JD Available from: http://www.eacsociety.org/files/guidelines_8.0-english-revised_2016-0610.pdfAccessed April 12, 2017
   Google Scholar
• Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and AdolescentsChair and Coordinator: Churchill D Available from: http://www.bhiva.org/documents/Guidelines/Treatment/2015/2015-treatment-guidelines.pdfAccessed April 12, 2017
   Google Scholar
• LabbettWGarcia-DiazAFoxZComparative evaluation of the ExaVirTM Load version 3 reverse transcriptase assay for the measurement of HIV-1 plasma viral loadJ Clin Microbiol200947103266327019656978
   PubMed Web of Science ®Google Scholar
• GandhiRTDeeksSGPlasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough?Clin Infect Dis201254573373522238162
   PubMed Web of Science ®Google Scholar
• GoldmanJDCantrellRAMulengaLBSimple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapyAIDS Res Hum Retroviruses20082481031103518724803
   PubMed Web of Science ®Google Scholar
• FairleyCKPermanaAReadTRHLong-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic settingHIV Med20056536636916156886
   PubMed Web of Science ®Google Scholar
• WoodEHoggRSYipBHarriganPRO’ShaughnessyMVMontanerJSEffect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350x10(9) cells/LAnn Intern Med20031391081081614623618
   PubMed Web of Science ®Google Scholar
• MaggioloFCallegaroACologniGUltrasensitive assessment of residual low-level HIV viremia in HAART treated patients and risk of virologic failureJ Acquir Immune Defic Syndr201260547348222481602
   PubMed Web of Science ®Google Scholar
• PalmerSMaldarelliFWiegandALow-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapyProc Natl Acad Sci U S A2008105103879388418332425
   PubMed Web of Science ®Google Scholar
• HatanoHDelwartELNorrisPJEvidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individualsAIDS201024162535253920651585
   PubMed Web of Science ®Google Scholar
• HavlirDVKoelschKKStrainMCGilead 903 Study TeamPredictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudineJ Infect Dis200519171164116815747253
   PubMed Web of Science ®Google Scholar
• DoyleTSmithCVitielloPPlasma HIV-1 RNA detection below 50 copies/mL and risk of virologic rebound in patients receiving highly active antiretroviral therapyClin Infect Dis201254572473222238167
   PubMed Web of Science ®Google Scholar
• CharpentierCLandmanRLaouenanCPersistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcomesJ Antimicrob Chemother20126792231223522643190
   PubMed Web of Science ®Google Scholar
• HenrichTJWoodBRKuritzkesDRIncreased risk of virological rebound in patients with antiviral therapy with a detectable HIV load <48 copies/mLPLoS One2012711e5006523166820
   PubMed Web of Science ®Google Scholar
• GianottiNGalliLSalpietroSVirological rebound in human immunodeficiency virus-infected patients with or without residual viraemia: results from an extended follow-upClin Microbiol Infect20131912E542E54423890370
   PubMed Web of Science ®Google Scholar
• BergKMArnstenJHPractical and conceptual challenges in measuring antiretroviral adherenceJ Acquir Immune Defic Syndr200643Suppl 1S79S8717133207
   PubMed Web of Science ®Google Scholar
• HessLMRaebelMAConnerDAMaloneDCMeasurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measuresAnn Pharmacother2006407–81280128816868217
   PubMed Web of Science ®Google Scholar
• DeschampsAEDe GeestSVandammeAMBobbaersHPeetermansWEVan WijngaerdenEDiagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standardsAIDS Patient Care STDS200822973574318754705
   PubMed Web of Science ®Google Scholar
• GrossbergRZhangYGrossRA time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIVJ Clin Epidemiol200457101107111015528063
   PubMed Web of Science ®Google Scholar
• HermankovaMRaySCRuffCHIV-1 drug resistance profiles in children and adults with viral load of <50 copies/mL receiving combination therapyJAMA2001286219620711448283
   PubMed Web of Science ®Google Scholar
• BaileyJRSedaghatARKiefferTResidual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cellsJ Virol200680136441645716775332
   PubMed Web of Science ®Google Scholar
• AndersonJAArchinNMInceWClonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cellsJ Virol201185105220522321367910
   PubMed Web of Science ®Google Scholar
• McMahonDJonesJWiegandAShort-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapyClin Infect Dis201050691291920156060
   PubMed Web of Science ®Google Scholar
• GandhiRTZhengLBoschRJAIDS Clinical Trials Group A5244 teamThe effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trialPLoS Med201078e100032120711481
   PubMed Web of Science ®Google Scholar
• LlibreJMBuzonMJMassanellaMTreatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week studyAntivir Ther201217235536422290239
   PubMed Web of Science ®Google Scholar
• ZhangLRamratnamBTenner-RaczKQuantifying residual HIV-1 replication in patients receiving combination antiretroviral therapyN Engl J Med1999340211605161310341272
   PubMed Web of Science ®Google Scholar
• CalcagnoAMottaIGhisettiVHIV-1 very low level viremia is associated with virological failure in highly active antiretroviral treatment-treated patientsAIDS Res Hum Retroviruses20153110999100826165150
   PubMed Web of Science ®Google Scholar
• HavlirDVStrainMCClericiMProductive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five yearsJ Virol20037720112121121914512569
   PubMed Web of Science ®Google Scholar
• RamratnamBRibeiroRHeTIntensification of antiretroviral therapy accelerates the decay of the HIV-1 latent reservoir and decreases, but does not eliminate, ongoing virus replicationJ Acquir Immune Defic Syndr2004351333714707789
   PubMed Web of Science ®Google Scholar
• PasternakAOde BruinMJurriaansSModest nonadherence to antiretroviral therapy promotes residual HIV-1 replication in the absence of virological rebound in plasmaJ Infect Dis201220691443145222927449
   PubMed Web of Science ®Google Scholar
• LiJZGallienSRibaudoHHeiseyABangsbergDRKuritzkesDRIncomplete adherence to antiretroviral therapy is associated with higher levels of residual HIV-1 viremiaAIDS20142818118624361679
   PubMed Web of Science ®Google Scholar